Trace amine-associated receptor, type 1 (TAAR1) as prospective target receptor for neuroleptics: From D-neuron study in postmortem brains of schizophrenia

被引：0
|
作者：
Ikemoto, K. [1 ]
机构：
[1] Iwaki Kyoritsu Gen Hosp, Iwaki, Fukushima, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-28-004
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
    Dodd, Seetal
    Carvalho, Andre F.
    Puri, Basant K.
    Maes, Michael
    Bortolasci, Chiara C.
    Morris, Gerwyn
    Berk, Michael
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 120 : 537 - 541
  • [2] A New Treatment Paradigm Targeting Trace Amine-Associated Receptor 1 (TAAR1) in Schizophrenia
    Kane, John M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (05) : S1 - S13
  • [3] Trace amine-associated receptor 1 (TAAR1) modulates dopaminergic activity
    Hoener, Marius Christian
    Lindemann, Lothar
    Meyer, Claas Aiko
    Jeanneau, Karine
    Bradaia, Amyaouch
    Ozmen, Laurence
    Bettler, Bernhard
    Wettstein, Joseph G.
    Borroni, Eddio
    Moreau, Jean-Luc
    FASEB JOURNAL, 2008, 22
  • [4] Challenges in the pharmacologic characterization of the trace amine-associated receptor 1 (TAAR1)
    Nelson, David L.
    Little, Sheila P.
    Yin, Tingqui
    Rocco, Vincent P.
    Wainscott, David B.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S133 - S134
  • [5] Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites
    Snead, Aaron N.
    Miyakawa, Motonori
    Tan, Edwin S.
    Scanlan, Thomas S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (22) : 5920 - 5922
  • [6] Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders
    Halff, Els F.
    Rutigliano, Grazia
    Garcia-Hidalgo, Anna
    Howes, Oliver D.
    TRENDS IN NEUROSCIENCES, 2023, 46 (01) : 60 - 74
  • [7] Trace Amine-Associated Receptor 1 (TAAR1): Molecular and Clinical Insights for the Treatment of Schizophrenia and Related Comorbidities
    Nair, Pramod C.
    Chalker, Justin M.
    McKinnon, Ross A.
    Langmead, Christopher J.
    Gregory, Karen J.
    Bastiampillai, Tarun
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2022, 5 (03) : 183 - 188
  • [8] Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders
    Dalvi, Saher
    Bhatt, Lokesh Kumar
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, : 5057 - 5075
  • [9] Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer
    Vogelsang, Tilman L. R.
    Vattai, Aurelia
    Schmoeckel, Elisa
    Kaltofen, Till
    Chelariu-Raicu, Anca
    Zheng, Mingjun
    Mahner, Sven
    Mayr, Doris
    Jeschke, Udo
    Trillsch, Fabian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [10] Pharmacological Characterization of Potent Human Trace Amine-Associated Receptor 1 (TAAR1) Agonists
    Saarinen, Marcus
    Diaz, Alejandro
    Agren, Richard
    Betari, Nibal
    Zeberg, Hugo
    Sahlholm, Kristoffer
    Carlsson, Jens
    Svenningsson, Per
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 391 - 391
12345